Diabetic medicine Ozempic now approved by Health Canada to reduce the risk of further kidney decline among patients with Type ...

Canada has approved Novo Nordisk's diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of ...

TORONTO — Health Canada has approved Ozempic to reduce the risk of further kidney decline among patients with Type 2 diabetes ...

Health Canada has approved Ozempic in an effort to help reduce the risk of kidney decline for patients living with Type 2 ...

Novo Nordisk announced today that Ozempic® (semaglutide injection) is now approved as the first-and-only medication indicated for both the once-weekly ...

Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as January.

The weight loss injectable Ozempic has faced several lawsuits in 2025 from people who had a negative experience with the ...

GLP-1 drugs like Ozempic and Wegovy have been linked to a host of benefits beyond diabetes management and weight loss, from reduced dementia risk and decreased cancer risk to addiction treatment.

If the shoe fits. Ozempic and other weight loss drugs could have a gnarly side effect dubbed “Ozempic-feet,” according to a report. The popular pound-shedding prescription drug is known… ...

Novo Nordisk’s preliminary update for the first six months of 2025 reported an 18% sales increase and 29% operating profit growth at CER, driven primarily by its GLP-1 drugs, Ozempic and Wegovy.

Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients ...